- Investing Ideas
- Global Pharmaceuticals & Biotech Breakout Stocks
Global Pharmaceuticals & Biotech Breakout Stocks
Results
25
Stocks where the price continues to rise after more than a year of consistent gains.
25 companies
uniQure
Market Cap: US$3.1b
Develops treatments for patients suffering from rare and other devastating diseases in the United States.
QURE
US$44.06
7D
20.2%
1Y
214.7%
Bausch Health Companies
Market Cap: US$2.6b
Operates as a diversified specialty pharmaceutical and medical device company.
BHC
US$7.00
7D
54.9%
1Y
17.8%
CareDx
Market Cap: US$2.5b
Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.
CDNA
US$47.85
7D
33.8%
1Y
272.4%
Replimune Group
Market Cap: US$1.0b
A clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer in the United States and the United Kingdom.
REPL
US$11.91
7D
122.6%
1Y
88.4%
GlaxoSmithKlineE
Market Cap: ج.م28.8b
Engages in production of pharmaceutical chemicals.
BIOC
ج.م345.25
7D
107.4%
1Y
623.8%
Egyptian International Pharmaceutical Industries
Market Cap: ج.م25.3b
Manufactures and sells pharmaceutical ampoules in Egypt and internationally.
PHAR
ج.م149.76
7D
60.3%
1Y
192.2%
iX Biopharma
Market Cap: S$588.2m
A specialty pharmaceutical and nutraceutical company, develops, manufactures, and commercializes therapies for the treatment of acute and breakthrough pain, and other health conditions in Singapore, the United States, China, and Australia.
42C
S$0.54
7D
27.1%
1Y
2,742.1%
Anika Therapeutics
Market Cap: US$241.8m
A joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally.
ANIK
US$19.28
7D
29.0%
1Y
123.1%
Thor Medical
Market Cap: NOK 2.0b
Produces and supplies alpha-particle emitters for cancer therapy in Norway.
TRMED
NOK 5.66
7D
26.3%
1Y
129.1%
Entera Bio
Market Cap: US$145.4m
A clinical stage company, engages in the development of oral peptides and protein replacement therapies in Israel and internationally.
ENTX
US$2.99
7D
45.9%
1Y
53.3%
Nyrada
Market Cap: AU$169.1m
A pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular and neurological diseases.
NYR
AU$0.69
7D
24.5%
1Y
114.1%
Eloxx Pharmaceuticals
Market Cap: US$74.5m
A clinical-stage biopharmaceutical company, develops small-molecule product candidates that modulate the ribosome and promote readthrough of premature stop codons caused by nonsense mutations in the United States, Israel, and Australia.
ELOX
US$18.45
7D
44.0%
1Y
1,678,698.9%
Medico Remedies
Market Cap: ₹4.1b
Develops, manufactures, and sells pharmaceutical and nutraceutical products in India.
540937
₹50.00
7D
23.0%
1Y
25.1%
BetterLife Pharma
Market Cap: US$39.7m
A biotechnology company, engages in the development of psychedelic-derived compounds.
BETR.F
US$0.24
7D
48.5%
1Y
274.0%
Sabaa International Company for Pharmaceutical and Chemical Industry
Market Cap: ج.م1.3b
Operates as a healthcare company in Egypt.
SIPC
ج.م5.00
7D
24.7%
1Y
55.8%
Devonian Health Group
Market Cap: CA$28.2m
Operates as a clinical stage biopharmaceutical corporation with novel therapeutic approaches targeting unmet medical needs in Canada and Internationally.
GSD
CA$10.14
7D
35.2%
1Y
12.7%
Medicure
Market Cap: CA$12.3m
A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.
MPH
CA$1.30
7D
25.0%
1Y
17.1%
Blueberries Medical
Market Cap: CA$9.9m
A consumer science company, engages in the commercialization of medicinal cannabis and related products in Colombia.
BBM
CA$0.02
7D
33.3%
1Y
100.0%
Panacea Life Sciences Holdings
Market Cap: US$5.5m
Operates as a holding company, researchers, develops, manufactures, produces, and distributes cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products for humans and animals.
PLSH
US$0.092
7D
23.2%
1Y
185.1%
Cannabis Global
Market Cap: US$789.6k
Focuses on the creating and commercialization of engineered technologies to deliver hemp extracts and cannabinoids to the human body.
CBGL
US$0.0001
7D
100.0%
1Y
0%
Rimrock Gold
Market Cap: US$576.8k
Through its subsidiary, focuses on the development and marketing a line of CBD oils, creams, and hemp extracts.
RMRK
US$0.0003
7D
20.0%
1Y
0%
Endonovo Therapeutics
Market Cap: US$180.8k
A biotechnology company, engages in the development, manufacture, and distribution of non-invasive Electroceutical medical devices for regenerative medicine.
ENDV
US$0.0001
7D
9,900.0%
1Y
0%
Affymax
Market Cap: US$111.7k
Does not have significant operations.
AFFY
US$0.0015
7D
50.0%
1Y
87.5%
PaxMedica
Market Cap: US$63.1k
A clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms.
PXMD
US$0.0007
7D
40.0%
1Y
600.0%
MPX International
Market Cap: US$14.4k
Operates as a cannabis company in Canada and internationally.
MPXO.F
US$0.0001
7D
9,900.0%
1Y
9,900.0%